论文部分内容阅读
白细胞介素-2(IL-2)是由活化T细胞所分泌的一种淋巴因子,通常对T细胞原微粒的表达起作用。重组的IL-2(rIL-2)作为一种生物抗癌治疗的药物,据报道对晚期恶性肿瘤有治疗反应。但治疗中常伴发多脏器的副反应。然而在文献中尚未被提到。本文初步研究rIL-z治疗患者的口腔症状、体征及唾液腺功能。方法 5例播散性黑素瘤住院患者接受了rIL-2
Interleukin-2 (IL-2) is a lymphokine secreted by activated T cells and usually plays an important role in the expression of T cell protomicroparticles. Recombinant IL-2 (rIL-2) is a biological anti-cancer drug that has been reported to have a therapeutic response to advanced malignant tumors. However, the side effects of multiple organs are often associated with treatment. However, it has not been mentioned in the literature. This article presents a preliminary study of oral symptoms, signs, and salivary gland function in patients treated with rIL-z. Methods Five hospitalized patients with disseminated melanoma received rIL-2